Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):e87–e93. doi: 10.1097/QAI.0b013e318292f9cd

Table 1.

Enrollment characteristics and ART regimens of children providing samples for pooled VL testing.

Enrollment characteristics* Archived samples
(N=100)
N (%) or
Median (IQR)
Real-time samples
(N=125)
N (%) or
Median (IQR)
Age (years) 4.7 (2.7, 6.6) 5.9 (4.0, 7.9)
Male 56 (56) 75 (60)
Height (cm) 96 (83, 108) 111 (100, 121)
Weight (kg) 14 (10, 17) 19 (15, 22)
CD4%a 7 (4, 13) N/A
CD4 countb 352 (102, 659) 843 (470, 1167)
HIV-1 viral load (copies//ml)c 872,400 N/A
(287,900 – 2,822,300)
HAART regimen
   NVP/3TC/AZT 52 (52) 29 (23)
   NVP/3TC/ABC 0 27 (22)
   NVP/3TC/D4T 12 (12) 8 (6)
   EFV/3TC/AZT 23 (23) 26 (21)
   EFV/3TC/ABC 0 30 (24)
   EFV/3TC/D4T 9 (9) 2 (2)
   LPVr//3TC/AZT 0 1 (1)
   LPVr//3TC/ABC 0 1 (1)
   3TC/AZT/ABC 2 (2) 1 (1)
   3TC/D4T/ABC 1 (1) 0
   3TC/AZT/NFV 1 (1) 0
*

Children in the archived samples cohort were initiated on ART soon after enrollment, while children in the real-time samples cohort had been on ART for 4 to 72 months at the time of enrollment.

a

CD4% results were available from N=88 children in the archived samples cohort, and were not collected from children in the real-time samples cohort.

b

CD4 count results were available from N=86 children in the archived samples cohort, and for N=20 children in the real-time samples cohort.

c

HIV-1 VL results were available from N=88 children in the archived samples cohort, and were not collected from children in the real-time samples cohort.